PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of diabetesSubscribeSearchDiabetes JournalAmerican Diabetes Association
 
Diabetes. 2009 November; 58(11): 2583–2587.
Published online 2009 August 20. doi:  10.2337/db09-0833
PMCID: PMC2768171

Brown Adipose Tissue and Seasonal Variation in Humans

Abstract

OBJECTIVE

Brown adipose tissue (BAT) is present in adult humans where it may be important in the prevention of obesity, although the main factors regulating its abundance are not well established. BAT demonstrates seasonal variation relating to ambient temperature and photoperiod in mammals. The objective of our study was therefore to determine whether seasonal variation in BAT activity in humans was more closely related to the prevailing photoperiod or temperature.

RESEARCH DESIGN AND METHODS

We studied 3,614 consecutive patients who underwent positron emission tomography followed by computed tomography scans. The presence and location of BAT depots were documented and correlated with monthly changes in photoperiod and ambient temperature.

RESULTS

BAT activity was demonstrated in 167 (4.6%) scans. BAT was demonstrated in 52/724 scans (7.2%) in winter compared with 27/1,067 (2.5%) in summer months (P < 0.00001, χ2 test). Monthly changes in the occurrence of BAT were more closely related to differences in photoperiod (r2 = 0.876) rather than ambient temperature (r2 = 0.696). Individuals with serial scans also demonstrated strong seasonal variation in BAT activity (average standardized uptake value [SUVmax] 1.5 in July and 9.4 in January). BAT was also more common in female patients (female: n = 107, 7.2%; male: n = 60, 2.8%; P < 0.00001, χ2 test).

CONCLUSIONS

Our study demonstrates a very strong seasonal variation in the presence of BAT. This effect is more closely associated with photoperiod than ambient temperature, suggesting a previously undescribed mechanism for mediating BAT function in humans that could now potentially be recruited for the prevention or reversal of obesity.

Brown adipose tissue (BAT) was first discovered several hundreds of years ago (1). Extensive research has been conducted in animals to elucidate its function. BAT has been proven to be important in small mammals for nonshivering thermogenesis, particularly following hibernation (2). BAT often coexists with white adipose tissue (WAT) and is structurally very different (3). WAT is unilocular containing a large single vacuole, whereas BAT is multilocular containing large complex mitochondria with a rich vascular supply and is extensively innervated by the sympathetic nervous system. The functions of WAT and BAT differ. WAT acts as a chemical store and an insulator. BAT, however, enables rapid heat production directly from the metabolism of triglycerides, suitable for nonshivering thermogenesis. This function is important in mammals and also helps to counteract the cold stress of birth in newborn mammals including humans (4). BAT is activated by the cold, a function mediated by the sympathetic nervous system (2), and is capable of producing up to 300 times more heat per unit mass compared with all other tissues (5). Uncoupling protein (UCP)-1 is exclusively expressed in brown adipocytes and uncouples oxidative phosphorylation from respiration and the production of ATP, resulting in the production of large amounts of heat (2).

BAT is thought to have a protective role against obesity because genetic knockout mice lacking BAT become obese (6). Strong recent evidence for the existence of active BAT in adults has come from positron emission tomography (PET)/computed tomography (CT) imaging, a technique enabling the visualization and anatomical localization of sites of glucose metabolism. Sites of high activity are seen within adipose tissue, particularly in adipose located in the supraclavicular regions but also in paraspinal and suprarenal regions. Three recent studies have demonstrated the presence of UCP-1 in areas corresponding to these areas of activity on PET/CT. Biopsy of the supraclavicular areas of activity confirmed the presence of BAT at this site, providing conclusive evidence for the presence of active BAT in adult humans (7,8,9). Although very likely to represent BAT, the other sites of presumed BAT activity have not been definitively confirmed on biopsy samples.

The purpose of our study was to further examine the characteristics of BAT expression in a large cohort of adults undergoing PET/CT at our institution and to determine how this related to time of year. We specifically focused on the impact of photoperiod and ambient temperature because these are two key factors determining BAT function in small mammals (10,11).

RESEARCH DESIGN AND METHODS

A total of 3,614 consecutive patients underwent PET/CT scans between 14 March 2006 and 30 October 2008 at the Nottingham PET/CT center (53.00°N 1.20°W). These scans were mostly performed for cancer staging. Patients were fasted for at least 6 h prior to their appointments. All scans were acquired using a Siemens Biograph 16 HiRez LSO PET/CT scanner. The majority of scans were performed from skull vertex to upper thigh. Temperature was not kept constant at the PET/CT center throughout the year, although there is a thermostat in the room and indoor temperature significantly exceeds outdoor temperature. Patients were indoors for at least 75 min to allow for 18F-fluorodeoxyglucose injection and uptake prior to imaging.

Patients expressing BAT activity were identified via retrospective review of radiology reports. The presence of BAT activity is routinely included in the radiology report at our institution. The 154 patients with BAT activity constituted the study group. Data were also obtained about age, sex, BMI, serum glucose, month scanned, and disease. The location of BAT depots was recorded in each of these patients.

Patients who underwent serial scans were identified, and variation of BAT expression in these individuals was recorded. BAT activity was quantified by calculating the maximum standardized uptake value (SUVmax) within a specified region of interest using a Leonardo workstation in the area of maximal activity in these patients. Assessment of depots was made by a single observer experienced in PET/CT interpretation.

Quantification.

The SUVmax is dependent on a number of factors including time between injection and imaging, blood glucose, patient weight, and the equipment used (12). Although serial SUVmax measurements are more reproducible in individuals, a semiquantitative method of analyzing the intensity of BAT depots was also developed to give an approximate estimate of the amount of BAT present in an individual. The five main depots (supraclavicular, mediastinal, axillary, paravertebral, and abdominal) were analyzed, and the amount of activity in each was assigned a score (0 = absent, 1 = low grade, 2 = moderate, 3 = high grade) that was then was summated for the five major depot sites to provide a total intensity score (0–15). The total number of positive depots was also used as a quantitative index.

Statistical analysis.

All statistical analyses were performed using SPSS version 16.0 for windows (SPSS, Chicago, IL). A χ2 test was performed to ascertain whether there was a significant relationship between sex and total number of BAT-positive scans and between season and total number of BAT-positive scans.

RESULTS

Characteristics of BAT expression.

The prevalence of BAT activity in this cohort of patients was 4.6% (n = 167/3,614) with the location summarized in Table 1. Overall, BAT was most often observed in the supraclavicular region.

TABLE 1
Frequency of reporting of BAT-positive anatomical depots with average age in years for each depot

Sexual dimorphism.

In male patients, 2.8% of scans demonstrated BAT activity (n = 60/2,131) compared with 7.2% of scans in female patients (n = 107/1,483). The difference between male and female patients was highly significant (P = 0.00005, χ2 test). Irrespective of sex, for the 57 patients in whom BMI data were available, there was a trend for BAT-positive individuals to have a low BMI, with a smaller proportion being obese.

Seasonal variation.

The proportion of patients with BAT activity showed a very striking seasonal variation, being highest in winter and lowest in summer (Fig. 1A and B). The month-to-month circannual variation is even more striking because it is inversely correlated with average monthly temperatures and positively related to night length in Nottingham as recorded through the study period (Fig. 1C and D). Additionally, the number of depots identified also varied with season, with more depots identified in winter than summer (Fig. 1E). The difference in the monthly number of patients in which BAT activity observed was therefore positively correlated with night length (r2 = 0.876; P < 0.00001; Pearson Correlation) and negatively correlated with ambient temperature (r2 = 0.696; P < 0.001).

FIG. 1.
Seasonal variation in the occurrence of BAT in adults. Results are expressed as either the number of individual depots recorded (A) or the percentage of all scans (B) together with the variation in ambient temperature (http://www.tutiempo.net/en/climate/united_kingdom/gb.html ...

The seasonal variation in BAT activity was also apparent in those individuals who were scanned in different months (Fig. 2), with the mean SUVmax value being ~4 times higher in winter compared with summer (average SUVmax 1.5 in July and 9.8 in January). Indeed, some patients with active BAT in winter showed no activity in the summer. These effects were all independent of sex.

FIG. 2.
Effect of month of year on individual changes in SUVmax of BAT. Each line represents an individual patient who underwent serial PET/CT scans throughout the study period, with the total number of patients being 16.

Age.

The age range of the BAT-positive cohort was 13–88 years (average age 51.8 years), and there was a trend for both the average number of depots identified and the semiquantitative BAT score to decrease with increasing age (see Fig. 3A and B), although the latter effect is primarily due to the decreasing number of depots.

FIG. 3.
Effect of age on the occurrence of BAT in adults. Results are expressed as either the mean total intensity (A) or the number of individual depots recorded (B). A total of 71 scans were analyzed because not all were available for this type of analysis. ...

Cancer versus noncancer patients and type of medication.

In the BAT cohort, 11/167 (6.6%) of patients did not have a diagnosis of cancer, and all were investigated for solitary pulmonary nodules. Of those with cancer, 111/156 (71.2%) had active disease and 45/156 were in remission (28.9%). A similar distribution was seen in scans of patients not exhibiting BAT activity. There was also no relationship between the plasma glucose and the occurrence of BAT activity, with all patients being normoglycaemic (data not shown).

DISCUSSION

Obesity is a significant cause of morbidity and mortality, and there has been considerable recent interest in studying the physiology of BAT in humans, given its protective role against obesity in animal experiments (6). A greater understanding of BAT function could thus help to develop treatment strategies for obesity, especially because it appears that white adipocyte area is smaller in individuals possessing UCP-1 (13). One of the most striking findings of our study is the pronounced seasonal variation in BAT expression seen in the entire cohort of patients, in individuals, and in the number of depots that are active. To our knowledge, this is the largest study of its kind documenting the distribution of active BAT in multiple depots in adults and how BAT varies with season. Two smaller studies have demonstrated increased BAT activity in winter and/or early spring (14), although other studies have not confirmed this finding (15,16). We thus extend the findings from a small Japanese cohort (17) in which the variation in temperature was much greater than in the U.K. Importantly, we raise the question whether it is the prevailing ambient temperature or photoperiod that may be the primary factor determining BAT activity.

Cold exposure is established to promote BAT activity in both rodents (2) and humans (8). The extent to which it is the primary regulator of BAT function remains uncertain because photoperiod can also determine BAT activity irrespective of ambient temperature, although this effect is enhanced in the cold (18,19). Photoperiod is known to impact on prolactin release (20), which increases with day length (21). Prolactin administration also promotes the loss of UCP-1 (22), and prolactin secretion can be temperature sensitive (23). The prolactin receptor is essential for BAT function in the newborn (24), in whom the direct stimulation of prolactin receptor promotes BAT thermogenesis (25). It is thus possible that prolactin is an important factor determining the overall activity of BAT we have observed with season. This would explain why BAT that is inactive in the summer is then recruited in the winter for nonshivering thermogenesis, evidenced by increased activity within depots and a greater number of depots. Furthermore, it should be noted that patients undergoing scans are in a warm environment (indoors) while being prepared for their scans. The persistence of the strong variation in BAT activity despite stable indoor temperatures could thus relate to the longer-term recruitment of BAT depots (10). Although prolactin may be an important mediator, as discussed, the endocrine mechanisms controlling BAT expression are likely to be complex and other hormones, for example the key player in mediating circannual rhythms in mammals melatonin, are likely to be involved (26).

An understanding of the physiology of BAT is likely to be important if recruitment of BAT is to be considered as a strategy for weight loss in obese individuals. Global temperatures are rising in conjunction with increased use of artificial lighting and central heating (27). Our results demonstrate that seasonality and, thus, photoperiod and/or ambient temperature are pivotal determinants of BAT activity in adult humans. In fact, the abundance of BAT quadrupled between the summer and winter months in our study, thus emphasizing the importance of considering the time of the year in weight loss programs. The success or the failure of dietary or pharmacological interventions aimed at weight loss in obesity could depend on the capacity of BAT to burn excess energy. This raises the question as to whether the greater quantity of BAT we possess during the winter could be used to promote fat mobilization at this time of year.

Our study also demonstrated significantly increased prevalence of BAT in female patients, a finding that is consistent with other studies (9,14). Sexual dimorphism also exists in animal studies. Female rats have higher levels of UCP-1 in the interscapular BAT depot compared with males when housed at the same temperature, suggesting that they may have a lower temperature threshold for cold-induced thermogenesis (28). Sexual dimorphism in endocrine control of BAT may explain these differences. BAT function is dependent on thyroid hormones (29), which may be under the control of estrogen in female rats. BAT also expresses estrogen receptors, which may further explain these differences (2).

One caveat is that the study group mostly consists of patients undergoing treatment for cancer, although this is unlikely to affect the seasonal variation in BAT activity. It has been suggested that BAT activity may in part relate to increased expression of UCP-1 in cancer patients (30). In the present study, however, BAT was shown to be present in a significant proportion of noncancer patients, as well as those that were in remission, indicating that the presence of BAT is not exclusively due to cancer-related factors.

In conclusion, our large retrospective study demonstrates the presence of a strong seasonal variation in BAT activity (9) both in a cohort and in individual patients. Improved understanding of the influence of both photoperiod and ambient temperature on BAT function is likely to lead to the development of novel treatments for obesity.

Acknowledgments

Financial support for the project was provided by the Nottingham Digestive Diseases Biomedical Research Unit and the Respiratory Biomedical Research Unit.

No potential conflicts of interest relevant to this article were reported.

Parts of this study were presented in abstract form at the 37th annual meeting of the British Nuclear Medicine Society, Manchester, U.K., 27–29 April 2009.

We thank Kevin Hines for his help with accessing the database and staff at the Nottingham PET/CT unit.

Footnotes

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

REFERENCES

1. Gessner K.: Conradi Gesneri Medici Tigurine Historiae Animalium Lib. I De Quadripedibus Uiuiparis 842(1551)
2. Cannon B, Nedergaard J.: Brown adipose tissue: function and significance. Physiol Rev 2004;84:277–359 [PubMed]
3. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC, Spiegelman BM.: Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 1999;98:115–124 [PubMed]
4. Blaza S.: Brown adipose tissue in man: a review. J R Soc Med 1983;76:213–216 [PMC free article] [PubMed]
5. Power G.: Biology of temperature: the mammalian fetus. J Dev Physiol 1989;12:295–304 [PubMed]
6. Lowell BB, S-Susulic V, Hamann A, Lawitts JA, Himms-Hagen J, Boyer BB, Kozak LP, Flier JS.: Development of obesity in transgenenic mice after genetic ablation of brown adipose tissue. Nature 1993;366:740–742 [PubMed]
7. Virtanen KA, Lidell ME, Orava J, Heglind M, Westergren R, Niemi T, Taittonen M, Laine J, Savisto NJ, Enerback S, Nuutila P.: Functional brown adipose tissue in healthy adults. N Engl J Med 2009;360:1518–1525 [PubMed]
8. van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, Drossaerts JM, Kemerink GJ, Bouvy ND, Schrauwen P, Teule GJ.: Cold-activated brown adipose tissue in healthy men. N Engl J Med 2009;360:1500–1508 [PubMed]
9. Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, Kuo FC, Palmer EL, Tseng YH, Doria A, Kolodny GM, Kahn CR.: Identification and importance of brown adipose tissue in adult humans. N Engl J Med 2009;360:1509–1517 [PMC free article] [PubMed]
10. Demas GE, Bowers RR, Bartness TJ, Gettys TW.: Photoperiodic regulation of gene expression in brown and white adipose tissue of Siberian hamsters (Phodopus sungorus). Am J Physiol Regul Integr Comp Physiol 2002;282:R114–R121 [PubMed]
11. Feldmann HM, Golozoubova V, Cannon B, Nedergaard J.: UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living at thermoneutrality. Cell Metab 2009;9:203–209 [PubMed]
12. Castell F, Cook GJ.: Quantitative techniques in 18FDG PET scanning in oncology. Br J Cancer 2008;98:1597–1601 [PMC free article] [PubMed]
13. Zingaretti MC, Crosta F, Vitali A, Guerrieri M, Frontini A, Cannon B, Nedergaard J, Cinti S.: The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue. Faseb J 2009;23:3113–3120 [PubMed]
14. Cohade C, Mourtzikos KA, Wahl RL.: “USA-Fat”: prevalence is related to ambient outdoor temperature-evaluation with 18F-FDG PET/CT. J Nucl Med 2003;44:1267–1270 [PubMed]
15. Rousseau J, Cossette L, Grenier S, Martinoli MG.: Modulation of prolactin expression by xenoestrogens. Gen Comp Endocrinol 2002;126:175–182 [PubMed]
16. Kim S, Krynyckyi BR, Machac J, Kim CK.: Temporal relation between temperature change and FDG uptake in brown adipose tissue. Eur J Nucl Med Mol Imaging 2008;35:984–989 [PubMed]
17. Saito M, Okamatsu-Ogura Y, Matsushita M, Watanabe K, Yoneshiro T, Nio-Kobayashi J, Iwanaga T, Miyagawa M, Kameya T, Nakada K, Kawai Y, Tsujisaki M.: High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes 2009;58:1526–1531 [PMC free article] [PubMed]
18. Klingenspor M, Klaus S, Wiesinger H, Heldmaier G.: Short photoperiod and cold activate brown fat lipoprotein lipase in the Djungarian hamster. Am J Physiol Regul Integr Comp Physiol 1989;257:R1123–R1127 [PubMed]
19. Wiesinger H, Heldmaier G, Buchberger A.: Effect of photoperiod and acclimation temperature on nonshivering thermogenesis and GDP-binding of brown fat mitochondria in the Djungarian hamster Phodopus s. sungorus. Pflugers Arch 1989;413:667–672 [PubMed]
20. Goldman BD, Matt KS, Roychoudhury P, Stetson MH.: Prolactin release in golden hamsters: photoperiod and gonadal influences. Biol Reprod 1981;24:287–292 [PubMed]
21. Steger RW, Bartke A, Goldman BD, Soares MJ, Talamantes F.: Effects of short photoperiod on the ability of golden hamster pituitaries to secrete prolactin and gonadotropins in vitro. Biol Reprod 1983;29:872–878 [PubMed]
22. Chan E, Swaminathan R.: Role of prolactin in lactation-induced changes in brown adipose tissue. Am J Physiol Regul Integr Comp Physiol 1990;258:R51–R56 [PubMed]
23. Vigas M, Celko J, Koska J.: Role of body temperature in exercise-induced growth hormone and prolactin release in non-trained and physically fit subjects. Endocr Regul 2000;34:175–180 [PubMed]
24. Viengchareun S, Servel N, Feve B, Freemark M, Lombes M, Binart N.: Prolactin receptor signaling is essential for perinatal brown adipocyte function: a role for insulin-like growth factor-2. PLoS ONE 2008;3:e1535. [PMC free article] [PubMed]
25. Pearce S, Budge H, Mostyn A, Genever E, Webb R, Ingleton P, Walker AM, Symonds ME, Stephenson T.: Prolactin, the prolactin receptor and uncoupling protein abundance and function in adipose tissue during development in young sheep. J Endocrinol 2005;184:351–359 [PubMed]
26. Dardente H.: Does a melatonin-dependent circadian oscillator in the pars tuberalis drive prolactin seasonal rhythmicity? J Neuroendocrinol 2007;19:657–666 [PubMed]
27. Keith SW, Redden DT, Katzmarzyk PT, Boggiano MM, Hanlon EC, Benca RM, Ruden D, Pietrobelli A, Barger JL, Fontaine KR, Wang C, Aronne LJ, Wright SM, Baskin M, Dhurandhar NV, Lijoi MC, Grilo CM, DeLuca M, Westfall AO, Allison DB.: Putative contributors to the secular increase in obesity: exploring the roads less travelled. Int J Obes (Lond) 2006;30:1585–1594 [PubMed]
28. Quevedo S, Roca P, Pico C, Palou A.: Sex-associated differences in cold-induced UCP1 synthesis in rodent brown adipose tissue. Pflugers Arch 1998;436:689–695 [PubMed]
29. Bianco AC, Silva JE.: Intracellular conversion of thyroxine to triiodothyronine is required for the optimal thermogenic function of brown adipose tissue. J Clin Invest 1987;79:295–300 [PMC free article] [PubMed]
30. Bing C, Russell ST, Beckett EE, Collins P, Taylor S, Barraclough R, Tisdale MJ, Williams G.: Expression of uncoupling proteins-1, -2 and -3 mRNA is induced by an adenocarcinoma-derived lipid-mobilizing factor. Br J Cancer 2002;86:612–618 [PMC free article] [PubMed]

Articles from Diabetes are provided here courtesy of American Diabetes Association